Salt Substitutes Significantly Lower High Blood Pressure Risk, Study Finds

Translate to Spanish or other 102 languages!

Using salt substitutes to reduce regular salt intake may help lower high blood pressure, research suggests. Image for illustration purposes
Using salt substitutes to reduce regular salt intake may help lower high blood pressure, research suggests. Image for illustration purposes
- Advertisement -
  • Excess salt consumption is a known risk factor for developing high blood pressure.
  • New research shows swapping regular table salt for a salt substitute could helpregulate blood pressure in older adults.
  • Salt substitutes help minimize sodium intake while increasing potassium intake, both of which are associated with healthy blood pressure levels.

Overconsumption of salt is a global driver of cardiovascular disease and high blood pressure.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/salt-substitutes-significantly-lower-high-blood-pressure-risk?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-02-13&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

How Dogs Benefit Mind and Soul

"Dogs are wonderful greeters. They're waiting for you to come home, and they're always happy to see you. In turn, this increases our feel-good hormones, like dopamine and serotonin,” explained Chivonna Childs, PhD.

Data Reveals US Illicit Fentanyl Use is Double That of Clinical Care

The largest study to date that quantifies and compares medical and illegal use of fentanyl in the United States suggests that illicit use is more than twice as common as medically based use. 

7 Crucial Caregiving Truths Families Often Overlook

If you clicked to read this story, or someone sent it to you, congratulations: You’re a caregiver.

Moderna and Merck Report Positive Phase 3 Results for Personalized Cancer Therapy

Moderna and Merck have reached a major clinical milestone after their investigational individualized cancer therapy, combined with Merck’s Keytruda, produced positive results in a Phase 3 study involving patients with high-risk melanoma.
- Advertisement -